These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21884661)

  • 1. [Restless legs syndrome and depression].
    Rasmussen J; Videbech P
    Ugeskr Laeger; 2011 Aug; 173(35):2113-7. PubMed ID: 21884661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
    García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
    Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Restless legs syndrome in patients on dialysis for kidney insufficiency: effect of medication].
    Hohl-Radke F; Aedtner F; Domröse U; Neumann KH; Staedt J
    Dtsch Med Wochenschr; 2008 Jan; 133(3):71-5. PubMed ID: 18186007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant medication use and restless legs syndrome in patients presenting with insomnia.
    Brown LK; Dedrick DL; Doggett JW; Guido PS
    Sleep Med; 2005 Sep; 6(5):443-50. PubMed ID: 16084763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does domperidone potentiate mirtazapine-associated restless legs syndrome?
    Chang CC; Shiah IS; Chang HA; Mao WC
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):316-8. PubMed ID: 16309808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Restless legs syndrome and psychiatric diseases].
    Sforza E; Cervena K
    Rev Med Suisse; 2006 Sep; 2(79):2108-10, 2112-4. PubMed ID: 17073178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management.
    Hornyak M
    CNS Drugs; 2010 Feb; 24(2):89-98. PubMed ID: 20088617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restless legs syndrome induced by citalopram: a psychiatric emergency?
    Perroud N; Lazignac C; Baleydier B; Cicotti A; Maris S; Damsa C
    Gen Hosp Psychiatry; 2007; 29(1):72-4. PubMed ID: 17189751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
    Fulda S; Wetter TC
    Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mirtazapine-induced worsening of restless legs syndrome (RLS) and ropinirole-induced psychosis: challenges in management of depression in RLS.
    Chopra A; Pendergrass DS; Bostwick JM
    Psychosomatics; 2011; 52(1):92-4. PubMed ID: 21300203
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of sleep EEG profiles of patients suffering from restless legs syndrome, restless legs syndrome and depressive symptoms, and major depressive disorders.
    Brand S; Lehtinen A; Hatzinger M; Holsboer-Trachsler E
    Neuropsychobiology; 2010; 61(1):41-8. PubMed ID: 19940519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ropinirole treatment for restless legs syndrome.
    Bogan RK
    Expert Opin Pharmacother; 2008 Mar; 9(4):611-23. PubMed ID: 18312162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic treatment in idiopathic restless legs syndrome: effects on subjective sleepiness.
    Kallweit U; Khatami R; Pizza F; Mathis J; Bassetti CL
    Clin Neuropharmacol; 2010; 33(6):276-8. PubMed ID: 21060282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
    Bliwise DL; Freeman A; Ingram CD; Rye DB; Chakravorty S; Watts RL
    Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excessive Daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment.
    Kallweit U; Siccoli MM; Poryazova R; Werth E; Bassetti CL
    Eur Neurol; 2009; 62(3):176-9. PubMed ID: 19602890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of high dose pergolide mesilate on restless legs syndrome associated with Parkinson disease].
    Imamura A; Tsuboi Y; Tanaka M; Obata T; Yamada T
    Rinsho Shinkeigaku; 2007 Apr; 47(4):156-9. PubMed ID: 17511286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute dopamine-agonist treatment in restless legs syndrome on heart rate variability during sleep.
    Manconi M; Ferri R; Zucconi M; Clemens S; Rundo F; Oldani A; Ferini-Strambi L
    Sleep Med; 2011 Jan; 12(1):47-55. PubMed ID: 20851046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of pramipexole for patients with restless legs syndrome (RLS) and RLS-related impairment of mood.
    Montagna P; Hornyak M; Ulfberg J; Hong SB; Koester J; Crespi G; Albrecht S
    Sleep Med; 2011 Jan; 12(1):34-40. PubMed ID: 20965780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenging issues: sleep-wake, augmentation and quality of life.
    Partinen M
    Sleep Med; 2007 Aug; 8 Suppl 2():S19-24. PubMed ID: 17562383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restless legs syndrome: understanding its consequences and the need for better treatment.
    Earley CJ; Silber MH
    Sleep Med; 2010 Oct; 11(9):807-15. PubMed ID: 20817595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.